Market Access/ News/ News GBT claims EU approval for sickle cell drug Oxbryta Phil Taylor EU, Global Blood Therapeutics, Oxbryta, regulatory approval, sickle cell disease 0 Comment Global Blood Therapeutics’ run of positive regulatory news for its oral sickle cell disease treatment Oxbryta has continued Share X GBT claims EU approval for sickle cell drug Oxbryta https://pharmaphorum.com/news/gbt-claims-eu-approval-for-sickle-cell-drug-oxbryta/
EU, Global Blood Therapeutics, Oxbryta, regulatory approval, sickle cell disease
0 Comment
